Skip to main content

Advertisement

SpringerLink
Log in

Terapia con metformina e rischio di acidosi lattica

  • Diabete e Metabolismo
  • Published:
L'Endocrinologo Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Bibliografia

  1. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR, American Diabetes Association (ADA), European Association for the Study of Diabetes (EASD) (2012) Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 35:1364–1379

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Fujita Y, Inagaki N (2017) Metformin: new preparations and nonglycemic benefits. Curr Diabetes Rep 17(1):5

    Article  Google Scholar 

  3. Bailey CJ, Turner RC, (1996) Metformin. N Engl J Med 334(9):574–579

    Article  CAS  PubMed  Google Scholar 

  4. Misbin RI, Green L, Stadel BV, Gueriguian JL, Gubbi A, Fleming GA (1998) Lactic acidosis in patients with diabetes treated with metformin. N Engl J Med 338(4):265–266

    Article  CAS  PubMed  Google Scholar 

  5. Glucophage (metformin hydrochloride) and Glucophage XR (extended release) prescribing information. Bristol Myers Squibb, Bristol (2009)

  6. Inzucchi SE, Lipska KJ, Mayo H, Bailey CJ, McGuire DK (2014) Metformin in patients with type 2 diabetes and kidney disease: a systematic review. JAMA 312(24):2668–2675

    Article  PubMed  PubMed Central  Google Scholar 

  7. Standard Italiani per cura del diabete mellito AMD–SID. http://www.standarditaliani.it/

  8. Burnett RW, Covington AK, Fogh-Andersen N, Külpmann WR, Maas AH, Müller-Plathe O, Siggaard-Andersen O, Van Kessel AL, Wimberley PD, Zijlstra WG, International Federation of Clinical Chemistry (IFCC), Scientific Division. Committee on pH, Blood Gases and Electrolytes (1995) Approved IFCC recommendations on whole blood sampling, transport and storage for simultaneous determination of pH, blood gases and electrolytes. Eur J Clin Chem Clin Biochem 33(4):247–253

    CAS  PubMed  Google Scholar 

  9. Salpeter SR, Greyber E, Pasternak GA, Salpeter EE (2010) Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis Cochrane Database Syst Rev 4:CD002967

    Google Scholar 

  10. DeFronzo R, Fleming GA, Chen K, Bicsak TA (2016) Metformin-associated lactic acidosis: current perspectives on causes and risk. Metabolism 65(2):20–29

    Article  CAS  PubMed  Google Scholar 

  11. Buse JB, DeFronzo RA, Rosenstock J, Kim T, Burns C, Skare S, Baron A, Fineman M (2016) The primary glucose-lowering effect of metformin resides in the gut, not the circulation: results from short-term pharmacokinetic and 12-week dose-ranging studies. Diabetes Care 39(2):198–205

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartimento di Medicina Clinica e Sperimentale, Sezione di Malattie del Metabolismo e Diabetologia, Università di Pisa, Via Paradisa 2, 56124, Pisa, Italia

    Angela Dardano, Giuseppe Daniele & Stefano Del Prato

Authors
  1. Angela Dardano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giuseppe Daniele
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stefano Del Prato
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Angela Dardano.

Ethics declarations

Conflitto di interesse

Gli autori dichiarano di non avere conflitto di interesse.

Consenso informato

Lo studio presentato in questo articolo non ha richiesto sperimentazione umana.

Studi su animali

Lo studio presentato non ha richiesto studi su animali.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dardano, A., Daniele, G. & Del Prato, S. Terapia con metformina e rischio di acidosi lattica. L'Endocrinologo 19 (Suppl 1), 1–2 (2018). https://doi.org/10.1007/s40619-018-0399-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40619-018-0399-2

Search

Navigation